Skip to main content
Equibles

ORBIMED ADVISORS LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1055951 New York, NY
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$45,473,352
+$22,617,207 QoQ
Shares Held
90,700
+95.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#302
of 2,620 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $219,279,875 across 4 Diagnostics & Research names. TMO ranks #3 (20.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
 583,700 $87,572,511
2 NTRA
Natera, Inc.
 262,000 $71,119,900
3 TMO
Thermo Fisher Scientific Inc.
This page 		90,700 $45,473,352
4 WAT
Waters Corp /De/
 40,300 $15,114,112

All Filings in TMO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $45,473,352 90,700
2026-03-31 $22,856,145 46,500
2025-12-31 $26,944,425 46,500
2025-09-30 $22,553,430 46,500
2025-06-30 $18,853,890 46,500
2025-03-31 $64,190,400 129,000
2024-12-31 $43,907,412 84,400
2024-09-30 $52,207,308 84,400
2024-06-30 $72,996,000 132,000
2024-03-31 $76,719,720 132,000
2023-12-31 $76,327,602 143,800
2023-09-30 $72,787,246 143,800
2023-06-30 $84,940,900 162,800
2023-03-31 $85,187,486 147,800
2022-12-31 $111,349,518 202,200
2022-09-30 $102,553,818 202,200
2022-06-30 $61,607,952 113,400
2022-03-31 $71,232,390 120,600
2021-12-31 $63,187,628 94,700
2021-09-30 $63,017,699 110,300
2021-06-30 $55,643,041 110,300
2021-03-31 $50,338,714 110,300
2020-12-31 $51,375,534 110,300
2020-09-30 $48,699,656 110,300
2020-06-30 $39,966,102 110,300
2020-03-31 $31,281,080 110,300